Delivery Order SPE2DB20D1100-SPE2DB24FA2D7

Award Date 2/13/24
Potential Completion Date 3/6/24
Potential Value $40K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a $40,462.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,020,471 XEOMIN 100 unit vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,747,877 units of XEOMIN 100 unit vials. The $1,310.60 contract has a completion date of March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and has also received a separate indefinite delivery contract (IDC) from DLA valued at up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $6,553.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,609,981 units of XEOMIN 100 unit vials. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC allows...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $7,125.00 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,563,205,093 units of the pharmaceutical product XEOMIN 50 UNIT VIALS. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,562,593 units of XEOMIN 100 unit vials. The contract has a potential value of $13,106.00 and a completion date of February 26, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,948 units of XEOMIN 100 unit vials. The $3,145.44 delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, serving as the primary vehicle for the company to provide pharmaceutical products and...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,834,250 units of XEOMIN 200 unit vials. The contract has a potential value of $3,145.50 and a completion date of March 22, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $44,036.16 contract is for the delivery of 4,563,871,394 vials of the pharmaceutical product XEOMIN 100 UNIT. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $15,727.20 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,671,379 units of XEOMIN 100 Unit Vials. The contract has a performance period through March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA2D7
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $40,004.40 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,657,192 units of XEOMIN 100 unit vials. This delivery order falls under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 5/14/24, 12:20 PM